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Abstract
 
Marginal zone (MZ) B cells play a major role in the first-line responses against blood-born
T-independent bacterial antigens (TI), but the full scope of their immune functions is not known.
Here we compare the responses of MZ and follicular (FO) B cells to a T-dependent antigen
(TD), hapten–(4-hydroxy-3-nitrophenyl)acetyl (NP) coupled to chicken 
 
 
 
-globulin, in a cell
transfer system. Consistent with the conventional paradigm, MZ B cells but not FO B cells
rapidly generated the early burst of NP-specific antibody-forming cells (AFC), high levels of
IgM Ab, and early IgG with relatively high affinity to NP. However, MZ B cells were also capable
of forming germinal centers (GCs) albeit with a delay, compared with FO B cells. The early
AFCs and the GCs originated from different MZ precursors, but the MZ- and FO-derived
GCs were similar in V
 
H
 
 gene repertoire, somatic mutation, and production of late AFC and
IgG Ab. Surprisingly, the MZ but not the FO memory response included IgM Ab. We conclude
that MZ B cells are heterogeneous, comprising cells for both early AFC response and GC/
memory pathway against TD antigens.
Key words: B cells • marginal zone • T-dependent Ag • antibody-forming cells • germinal center
 
Introduction
 
Newly formed B cells in adults migrate from BM to peripheral
lymphoid tissues where they continue to differentiate into
functionally and anatomically distinct subsets (1). Mature
peripheral B cells include B1 cells, which reside mainly in
peritoneal and pleural cavities (2), and the conventional B2
B cells. The mature B2 cell population is heterogeneous,
consisting of the major follicular B cells (FO), in LN and
splenic lymphoid follicles, and a subset residing in the marginal
zone (MZ) of the spleen (3). MZ and FO B cells are distin-
guished by differential expression of several cell surface
markers: MZ B cells are IgD
 
low
 
CD21
 
high
 
CD23
 
low/
 
 
 
, whereas
FO B cells are IgD
 
high
 
CD21
 
inter
 
CD23
 
high
 
 (4, 5). In addition,
MZ B cells express various activation markers, such as high
basal levels of CD80, CD86, CD40, and CD44, and low
level of CD62L (5, 6). As a functional corollary, MZ B cells
exhibit rapid and robust proliferation and Ig secretory re-
sponses to stimulation with LPS, anti-IgM, and CD40
ligands (5–7). The apparent hyperreactivity of MZ B cells
and their unique anatomic localization at the red pulp junction
strongly suggest that these B cells mediate rapid Ab responses
to blood-born antigens (8).
There is increasing evidence for selection of B cells into
the MZ or follicular pool through B cell receptor (BCR)–
mediated signals (9, 10). Studies on transgenic mice dem-
onstrated that B cells expressing BCR with specificity for
different Ags had accumulated either in the follicles or in
the MZ (11). In particular, B cells specific for the bacterial
epitope, phosphorylcholine, homed to MZ and responded
to the TI form of the Ag (3, 11). The ligands that control
cellular selection and homing are not known (3). Interestingly,
in humans (12, 13), and to a lesser extent in rats (14), some
MZ B cells express somatically mutated IgV genes, suggesting
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Abbreviations used in this paper:
 
 AFC, antibody-forming cell; BCR, B cell
receptor; CGG, chicken gammaglobulin; CSR, class-switch recombination;
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Streptavidin conjugated to alkaline phosphatase; SHM, somatic hyper-
mutation; TD, T-dependent Ag; TI, T-independent Ag; TI-I, TI type I
Ag; TI-II, TI type II Ag. 
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that they already encountered Ags and became memory
cells. Collectively, these findings suggest that the repertoire of
MZ B cells is skewed by stimulation with environmental Ags.
Fagarasan and Honjo (15) proposed that MZ B cells re-
spond to T-independent Ags (TI) and may not be regulated
by T cells. This notion was based primarily on the pheno-
type of Pyk-2–deficient mice (16) that had a severely re-
duced MZ B cell population and diminished Ab response
to TI type I Ag (TI-I) and TI type II Ag (TI-II). However,
this defect was restricted only to the IgG2a and IgG3 iso-
types, whereas IgG1 and IgG2b Ab responses to TI-I and
TI-II Ags were unaffected. Moreover, the disruption of
Pyk-2 also inhibited the IgM response to T-dependent Ags
(TD). These conflicting observations suggest that the func-
tion of MZ B cells and their relationship with T cells are
complex. Indeed, Tanigaki et al. (17) failed to find a rela-
tionship between MZ B cells and TI Ab responses. They
generated mice lacking expression of RBP-J, a mediator of
Notch signaling, in B cells using conditional mutagenesis.
Such mice had no MZ B cells, but Ab responses to TI-I,
TI-II, and TD Ag were unaffected.
The phenotypes of the Pyk-2 (16) and RBP-J (17) mu-
tants have shown that MZ B cells are not dedicated only to
TI Ab responses. MZ B cells present Ags and deliver co-
stimulatory signals to T cells more efficiently than FO B
cells in vitro (5), suggesting that MZ cells can mount rapid
Ab responses requiring cognate T cell help (18). Indeed,
using a hapten-carrier system, Liu et al. (19) demonstrated a
rapid appearance of specific, hapten-binding MZ B cells in
rats that had been primed previously to the carrier protein.
We hypothesized that the Ab response of MZ B cells to
TD Ags is qualitatively different from that of FO B cells
and that the two cell subsets differ in their potential to form
antibody-forming cells (AFC), germinal centers (GCs), and
memory cells. To test this prediction rigorously, we recon-
stituted 
 
scid
 
 mice with purified MZ and FO B cells from
naive WT C57BL/6 donors, supplemented them with car-
rier-primed T cells, and then stimulated the chimeras with
the hapten-(4-hydroxy-3-nitrophenyl)acetyl (NP) coupled
to chicken gammaglobulin (CGG). The NP-specific Ab
response of Igh
 
b
 
 mice has been well characterized at the
cellular and molecular level: NP-binding V
 
H
 
 regions are
encoded by the group of V186.2/V3 genes of the J558
family; the dominant clonotype expresses the V186.2 seg-
ment rearranged to DFL16.1/2 and J
 
H
 
2 segments in com-
bination with the 
 
 
 
 L chain (20–23). This response to NP
thus provides a precise tool for comparing potential differ-
ences between MZ and FO B cells in repertoire and func-
tion. Our results show an unexpected functional heteroge-
neity of MZ B cells. Upon stimulation with TD Ag, MZ
cells rapidly produce large numbers of AFC that have dis-
tinct clonotypic repertoire; however, these cells also give
rise to GCs with characteristic somatic hypermutation and
generate immunological memory.
 
Materials and Methods
 
Animals.
 
Normal C57BL/6, B6.SJL-Ly5.1 (CD45.1) (both
8–12 wk), and C57BL/6 
 
scid
 
 mice (8–10 wk) were purchased from
The Jackson Laboratories and maintained in microisolator cages in
the animal facility of the University of Maryland, Baltimore.
 
Antigens.
 
NP and its analogue (4-hydroxy-5-iodo-3-nitro-
phenyl)acetyl (NIP) (Cambridge Research Biochemical) were
conjugated at various substitution ratios to CGG (Sigma-Aldrich)
or BSA (Amersham Biosciences) as described (24).
Figure 1. Purification of splenic MZ and FO B cells. (a) T cell–depleted splenocytes were stained for CD21-FITC and CD23-PE, and the CD23hi FO
cells were separated by autoMACS with anti-PE beads (b). The CD23  fraction (c) was stained with B220-APC, and the B220 CD21hi MZ cells (d)
were separated by FACS® from the CD21  CD23  DN fraction (e). The FO and MZ B cell fractions were reanalyzed before the cell transfer (b and d). 
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Antibodies.
 
Anti-Thy1.2 (HO13–4), anti-CD4 (GK1.5), and
anti-CD8 (3.155) hybridomas (American Type Culture Collec-
tion), and anti-CD3 hybridoma (145–2C11, provided by Dr. Jef-
frey A. Bluestone, University of California, San Francisco, CA)
were grown in our laboratory, and the Abs were isolated from
culture supernatants by salt precipitation. Anti–B220-APC (RA-
6B2), anti–CD23-PE (B3B4), anti–CD21-FITC (7G6), anti–
CD19-PE (1D3), anti–CD11b-biotin (M1/70), anti–CD11c-
biotin (HL3), anti–CD45.2-biotin (104), anti–CD45.1-biotin
(A20), and GL-7-FITC were purchased from BD Biosciences.
Horseradish peroxidase (HRP)-conjugated goat anti–mouse IgM,
IgG, IgG1, IgG2a, IgG2b, IgG3, 
 
 
 
, and
 
  
 
 were obtained from
Southern Biotechnology Associates, Inc.
 
Purification of MZ, FO B Cells.
 
Single spleen cell suspensions
were prepared by grinding spleens between two frosted glass
slides in medium consisting of RPMI 1640 with 25 mM Hepes
(Life Technologies) and 0.5% BSA (Sigma-Aldrich). B cell–
enriched populations were prepared by depleting T cells using
two treatments with an antibody cocktail consisting of anti-CD4
(GK1.5), anti-CD8 (3.155), anti-Thy1.2 (HO-13–4), and normal
rabbit serum, at 37
 
 
 
C for 40 min. The enriched B cells were
stained with anti–CD23-PE on ice for 15 min followed by incu-
bating with anti-PE microbeads (Miltenyi Biotec), and the
CD23
 
 
 
 B cells (FO B cells) were separated from the CD23
 
 
 
 B
cells by autoMACS (Miltenyi Biotec). The CD23
 
 
 
 B cells were
further stained with anti–CD21-FITC and B220-APC, and the
CD21-high, B220-positive MZ B cells were purified by FACS
 
®
 
sorting (Moflo, DakoCytomation). The purity of FO B cells and
MZ B cells was 
 
 
 
97 and 95%, respectively (Fig. 1).
 
CD4 T Cell Preparation.
 
T cells were enriched by passing
splenocytes from CGG-primed C57BL/6 mice through nylon
wool (Wako BioProducts) columns according to the protocol
recommended by the manufacturer. The enriched T cells were
incubated with anti–B220-PE, anti–CD8-PE, anti–CD19-PE,
anti–I-A
 
b
 
-biotin, anti–CD11b-biotin on ice for 15 min followed
by incubating with Streptavidin microbeads and anti–PE micro-
beads at 4
 
 
 
C for 15 min. The CD4 T cells were purified by pass-
ing the above-stained cell suspension through a MACS LS col-
umn (Miltenyi Biotec). The resulting CD4 T cells contained
 
 
 
1% of CD8 T cells and B220-positive B cells.
 
Adoptive Transfer and Immunization.
 
 
 
2–2.5 
 
  
 
10
 
6
 
 of purified
MZ or FO B cells, together with 4 
 
  
 
10
 
6
 
 CGG-primed CD4 T
cells were injected i.v. into C57BL/6 
 
scid
 
 mice, and the recipients
were immunized i.p. with 40 
 
 
 
g of NP-CGG in alum. Blood
and/or spleen samples were collected for analysis of the primary
response at days 4, 8, 14, 36, 60, and 85. To measure memory re-
sponses, splenocytes from the recipient mice were collected at day
85 after primary immunization, and 5 
 
 
 
 10
 
6
 
 cells were transferred
into 
 
scid
 
 mice. The mice were challenged with 10 
 
 
 
g of soluble
NP-CGG i.p., and memory responses were examined at days 6
and 9 after the boost. The 
 
scid
 
 recipients that were not challenged,
and the recipients of naive splenocytes that received the boost
dose of soluble Ag served as controls.
In experiments with mixed B cells subsets, MZ cells were pre-
pared from C57BL/6 mice expressing the Ly5.2 allele of the
common leukocyte antigen CD45, whereas the FO cells and the
CD21
 
lo
 
CD23
 
 
 
 (labeled as “double negative”) B cells were from
BL6. SJL-Ly5.1 (CD45.1) donors.
 
Antibody Measurement.
 
Serum NP-specific Abs were mea-
sured by standard ELISA using 96-well plates coated with 100
 
 
 
g/ml of NIP
 
18
 
-BSA. The relative affinity of serum Ab was de-
termined by titration on ELISA plates coated with BSA coupled
to NIP at different ratios, respectively, NIP
 
4
 
-BSA and NIP
 
18
 
-
 
BSA. The plates were developed with HRP-conjugated goat Ab
specific for mouse IgG
 
1
 
 that is the major isotype of anti-NP Ab
(
 
 
 
80% of IgG) in this system. Binding (OD450) to each plate at
the linear portion of the titration curve was determined, and the
relative affinity of Ab was expressed by binding to NIP
 
4
 
-BSA as a
percentage of binding to NIP
 
18
 
-BSA (Eq. 1):
 
. (1)
 
Phenotypic Analysis of GC B Cells by FACS
 
®
 
.
 
Mice were
killed at 14 d after the cell transfer and immunization, and the
splenocyte suspension was stained with anti–CD19-PE, GL-7–
FITC, and biotinylated anti-CD45.2 (Ly5.2) or anti-CD45.1
(Ly5.1) followed by SA-APC. GC B cells were enumerated as
GL-7
 
 
 
/Ly5.1
 
 
 
 or GL-7
 
 
 
/Ly5.2
 
 
 
 cells within the CD19 gate.
 
Immunohistochemical Staining of GC and AFC and Microdissection
of Target Cells.
 
Frozen splenic sections were prepared and
stained as described previously (25). The specific, NP-reactive
GCs were identified by dual staining with peanut agglutinin
(PNA) coupled to horseradish peroxidase (PNA-HRP) (EY Lab-
oratories, Inc.) in combination with a biotinylated NIP-BSA fol-
lowed by Streptavidin conjugated to alkaline phosphatase (SA-
ALPH) (ImmunoPure). NP-specific AFCs were visualized as
plasmacytes stained with biotinylated NIP-BSA. These cells
formed typical foci close to the borders of B cell follicles.
PNA
 
 
 
NIP
 
 
 
 GC cells and NIP-positive AFC foci were recovered
using a sharpened micropipette controlled by micromanipulator
(model MM188; Nikon). The recovered cells were lysed with
PCR-lysing buffer (1
 
 
 
 PCR buffer containing 100 
 
 
 
g/ml pro-
teinase K, 0.05% Tween 20) at 56
 
 
 
C for 1 h followed by inactiva-
tion of proteinase at 95
 
 
 
C for 10 min. Resulting samples were
used for PCR amplification.
In mice reconstituted with cells expressing different CD45 al-
leles, the GCs in splenic sections were visualized by dual staining
with PNA-HRP and anti–Ly5.1-biotin plus SA-ALPH. The
dual-stained PNA
 
  
 
Ly5.1
 
 
 
 GCs were readily distinguishable from
single-stained PNA
 
 
 
Ly5.1
 
  
 
GCs in the same section (see Fig. 4 in
Results), and the latter were then scored as Ly5.2
 
 
 
. The anti-
Ly5.2 conjugate could not be used for identification of GCs in
sections because of the high background staining.
 
PCR Amplification, V
 
H
 
 Gene Repertoire Screening, and Mutation
Analysis.
 
Amplification of VDJ rearrangements using two pairs of
primers for nested PCR was performed as described previously
(25, 26). PCR products were cloned using pBluescriptSKII plas-
mid (Stratagene) and DH5
 
 
 
 
 
Escherichia coli
 
 and screened by hybrid-
ization with V
 
H
 
 gene–specific, 
 
32
 
P-labeled oligonucleotides (26).
All transformed colonies hybridized with the probe (5
 
 
 
-GTAGC-
CAGAAGCCTTGCAGGA-3
 
 
 
) corresponding to the region of
genomic DNA (aa position 21–27) that is shared by the V186.2/
V3 group of 22 genes of the J558 family. A proportion of these
colonies also hybridized with the probe (5
 
 
 
-TACCACCAC-
TATTAGGATCAATCCT-3
 
 
 
), which identifies a DNA region
(aa position 50–57) specific for the V186.2 gene sequence. The
number of 21–27
 
 
 
/50–57
 
 
 
 colonies has been shown to correlate
with the number of B cells expressing one of the analogue (non-
V186.2) genes of the V186.2/V3 group (26). Plasmid DNA from
the double-positive (21–27
 
 
 
/50–57
 
 
 
) colonies was extracted and
sequenced by the Biopolymer Laboratory of the University of
Maryland, School of Medicine using an automatic DNA sequenc-
ing system (Applied Biosynthesis). All double-positive colonies in-
variably yielded the rearranged V186.2 sequence. Mutations were
scored based on nucleotide substitutions in the V
 
H
 
 gene only.
affinity
OD450w.NIP4BSA ˙ 100 ×
OD450w ˙.NIP18BSA
-----------------------------------------------------------------
˙˙˙
= 
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Shared mutations within a set of clonally related sequences (ac-
cording to the CDR3) were counted as one mutational event.
 
Results
 
Distinct Cellular Responses of B Cell Subsets. Scid
 
 mice
were reconstituted with either highly purified MZ cells
(“MZ mice”) or FO cells (“FO mice”) plus carrier-primed
T
 
H
 
 cells as described in Materials and Methods and Fig. 1.
These recipients demonstrated marked differences in their
responses to immunization with NP-CGG (Fig. 2). MZ
mice exhibited an early extrafollicular AFC response with
the appearance of NP-binding plasma cells on day 4 and
large AFC foci formation by day 8 (Fig. 2, a and b),
whereas the formation of the GC was relatively slower.
Only few follicles stained faintly with PNA on day 8 (Fig. 2
c); PNA
 
 
 
 GCs were seen in less than half of splenic sec-
tions, numbering less than three GCs/section (Table I).
However, by day 14 the GCs in MZ mice reached typical
size (Fig. 2 d) and numbered up to six per section (Table I).
In contrast, FO mice had no AFC on day 4 (Fig. 2 e) and
only few, scattered NP-binding plasmacytes were found on
day 8 (Fig. 2 f); AFC foci were not seen until day 14 (not
depicted). However, FO mice developed large PNA
 
 
 
 GCs
from day 8 (Fig. 2 g) that were apparent in every splenic
section (Table I) and that continued on day 14 (Fig. 2 h).
Although the purity of MZ cells was 
 
 
 
95% (Fig. 1 d),
we considered the possibility that the GCs in MZ mice re-
sulted from a small (
 
 
 
5–10%) cell contamination. Since the
CD23
 
 
 
 FO cells were removed by autoMACS before
FACS
 
®
 
 sorting for MZ cells, we considered that the most
likely contamination was from the CD21
 
lo
 
/CD23
 
 
 
 double
negative (DN) immature B cells (9) that might have com-
pleted their maturation to FO cells and form GCs after the
adoptive transfer. We addressed this concern by reconsti-
tuting 
 
scid
 
 mice with purified Ly5.2
 
 
 
 MZ cells (2.7 
 
 
 
 10
 
6
 
)
that were mixed with 3   105 cells from the CD21lo/
CD23  B cells (Fig. 1 e) that were isolated from Ly5.1 
Figure 2. Visualization of NP-
binding AFC (blue) and PNA 
GC (red) in splenic sections from
scid mice reconstituted with either
MZ cells (a–d) or FO cells (e–h)
plus carrier-primed TH cells and
immunized with NP-CGG/alum.
Large foci of AFCs are seen in
MZ cell recipients on day 4 (a)
and 8 (b), whereas the FO cell
recipients show a few scattered
AFC on day 8 after the immuni-
zation (f). GC was rare in MZ
mice on day 8 (c; GC, sur-
rounded by AFC in dark blue)
but became frequent and large
on day 14 (d). Typical GCs were
present in FO mice on day 8 (g)
and 14 (h).
Table I. Germinal Centers in the Spleen of Mice with MZ and FO B Cells
Spleen sectionsa
Days postimmunization B cells transferred GC/section (range) Positive/totalb
8 MZ 0–3 10/21
0–1 1/4
FO 0–8 10/11
1–4 14/14
14 MZ 0–6 5/10
0–2 5/10
0–1 3/9
0–5 6/10
0–3 9/14
aSerial longitudinal sections were prepared from two to three spleens/group (20–50 sections through  50–60% of the splenic thickness). PNA+ ger-
minal centers were scored on several sections separated by  20–30  m.
bPositive sections contained at least one GC.Song and Cerny 1927
donors (see Materials and Methods). It should be empha-
sized that CD21 expression in the DN fraction is variable,
with a few cells staining nearly as bright as the MZ cells
(Fig. 1 c). Therefore, substantial numbers of GC B cells in
these chimeras should be Ly5.1  if the GCs originated
from the immature cells rather than MZ cells. However, at
14 d after the transfer and immunization, the numbers of
GC B cells were nearly proportional to the input: 90% of
GL-7  GC B cells were Ly5.2  by FACS® (Fig. 3 A, Table
II, Group A), and all but one GC in splenic section were
PNA /Ly5.1  (Table II, Group A). Thus, GCs in the MZ
mice do not arise from immature B cells.
MZ Cells Form GCs in Competition with FO Cells.  It
could be argued that in normal spleen the potential of MZ
Figure 3. Enumeration of GL-7  GC B cells in day 14 spleen by costaining for Ly5.1 (top) or Ly5.2 (bottom) within CD19 gate. The numbers in top
right corners show the percentage of CD19  Ly5.1  (or Ly5.2 ) cells that were GL-7 positive; the numbers in bottom right corners show the per-
centage of GL-7  B cells that did not express the allele. Groups of mice were reconstituted with B cell subsets of various ratios (numbers of cells are
shown in Table II): (A) Ly5.2  MZ   Ly5.1  DN cells, 9:1; (B) Ly5.2  MZ   Ly5.1  FO, 9:1, and (C) Ly5.2  MZ   Ly5.1  FO, 1:9.
Table II. Phenotypes of GC in Mice Reconstituted with MZ Plus FO and/or DN B Cells at Various Ratios
GC B cells in the recipient spleensa
Number of injected B cells FACS® analysis (%)b GC enumerationc
Group Ly5.2+ Ly5.1+
Ratio
(Ly5.2+/Ly5.1+) Ly5.2+GL-7+ Ly5.1+GL-7+
Ratio
(Ly5.2/Ly5.1) Ly5.1 PNA+ Ly5.1+PNA+
Ratio
(Ly5.1 /Ly5.1+)
A
MZ
2.7   106
DN
3   105 9:1 20 2 10 14.6   51 d 14
B
MZ
2.7   106
FO
3   105 9:1 16 10 1.6 17.4   4.7 7.4   3 2.4
C
MZ
3   105
FO
2.7   106 1:9 4 13 0.3 2.6   1 12.6   2.7 0.2
aDay 14 after adoptive transfer and immunization; three recipients/group.
bPieces ( 20%) of the spleens were pooled, stained, and gated on CD19 bright cells.
cNumber of PNA+ centers in 10 spleen sections; mean from three mice   SD. See Materials and Methods and Fig. 4 for details on visualization of
Ly5.1+ and Ly5.1-GC.
dOne PNA+ center was found in one out of three mice.Immune Responses of Marginal Zone B Cells to a T-dependent Antigen 1928
cells to form GCs is eclipsed by a much larger population
of FO cells. We examined this point by cotransferring the
purified Ly5.2  MZ cells and Ly5.1  FO cells at ratios of
9:1 (group B) and 1:9 (group C) together with TH cells.
The numbers and the Ly5 phenotype of splenic GL-7 
GC B cells at 14 d postimmunization were determined by
FACS®, and the phenotypes of PNA  GCs in splenic sec-
tions were shown by costaining with anti-Ly5.1 as de-
scribed in Materials and Methods. An example of the dual
staining is shown in a splenic section from group B that
contains three PNA  centers (Fig. 4 a): one dark purple
GC in the top right corner is clearly Ly5.1 /PNA , and
two bright red GCs in the bottom left corner are PNA /
Ly5.1  that were scored as Ly5.2 . The scoring of GCs by
this method was in general agreement with the FACS®
analysis (Table II). GC B cells in the mixed chimeras were
formed by either the Ly5.2  MZ cells or Ly5.1  FO cells,
and their respective numbers vary according to the cellular
input. Group B received nine times more Ly5.2  MZ cells
than Ly5.1  FO cells (ratio 9:1), but the numbers of
Ly5.2  GC B cells were only about twofold higher than
Ly5.1  GC B cells as determined by either FACS® (Fig. 3
B) or by section staining (Table II). This is consistent with
the notion that GC precursors in the FO cell subset are
more frequent and/or robust compared with MZ B cells.
However, this trend was not apparent when the MZ:FO
input ratio was reversed to 1:9 in group C (Table II). The
numbers of Ly5.2  GC B cells (Fig. 3 C) were nearly pro-
portional to the input of Ly5.2  MZ cells. It is conceivable
that these results were influenced by the mechanisms of
homeostasis and cell expansion that may be different for
MZ and FO subsets. Nevertheless, the results argue
strongly that the GCs detected in MZ mice are not derived
from contaminating FO cells.
Serum Antibody Responses. Consistent with the pattern
of cellular responses in single-reconstituted animals, the MZ
mice mounted a robust NP-specific IgM serum Ab response
during the first week after the immunization (Fig. 5 a) and
switched to IgG Ab on day 8 (Fig. 5 b). FO mice did not
produce any detectable serum Ab until day 8; the level of
IgM was 10-fold lower than in the MZ mice, whereas the
IgG titers had a similar range among individual mice in both
groups. Thus, the massive, early AFC formation in the MZ
mice correlates well with the anti-NP IgM response. The
origin of serum Ab in FO mice can be either from the dis-
persed plasmacytes (Fig. 2 f) or perhaps from B cells in the
follicles, which might have secreted Ig without differentia-
tion into typical plasmacytes. Interestingly, the MZ mice
maintained 10-fold higher IgM Ab titers throughout the
entire 2-mo period of observation, and as described below,
they also displayed a brisk, recall IgM Ab response to the Ag
boost. Each of the two independent experiments shown in
Fig. 5 included groups of control mice reconstituted either
with whole unseparated splenic B cell population together
with purified TH, or with TH alone, and immunized with
NP-CGG. Notably, mice with unseparated B cells main-
tained intermediate levels of IgM Ab relative to the MZ and
FO mice, confirming that MZ B cells, which represent
5–10% of spleen B cells, make the major contribution to
IgM responses. None of the mice from the control group
reconstituted with only T cells produced detectable anti-NP
serum Ab, demonstrating that neither a contaminating do-
nor B cell population nor “leaky” host B cells contributed
to the anti-NP responses (not depicted).
VD Gene Repertoire of Anti-NP Responses. The rear-
ranged VH genes in the NP-responding B cells in FO and
MZ mice were examined by screening bacterial transfor-
mants with probes that discriminate between the V186.2
segment and the remaining “analogue genes” of the
V186.2/V3 family. The VH gene repertoire was expressed as
the ratio between V186.2 and non-V186.2 (analogue) genes,
and the rearranged V186.2/D/J segments were sequenced.
The most prominent finding in the MZ mice was the
difference in the repertoire between the early AFC and the
GC. Most AFCs ( 70%) at day 8 used the V186.2 seg-
ment, but surprisingly few, if any, of those VH genes were
Figure 4. Phenotypes of day 14 germinal centers in
splenic sections in mice reconstituted with Ly5.2  MZ
cells (2.7   106) and Ly5.1  FO cells (3   105) plus TH
cells and immunized on the day of transfer. (a) Staining
with PNA-HRP (red) and anti–Ly5.1-biotin plus
SA-ALPH (blue) reveals one PNA Ly5.1  GC (pur-
ple) in the top right corner and two PNA Ly5.1  GC
(red) in bottom section. (b) Adjacent section stained for
PNA (red) and B220 (blue) demonstrates that the
PNA  clusters are B cells.Song and Cerny 1929
rearranged to the DFL16.1/2 segment (Fig. 6 a). Instead,
the CDR3 was encoded by DSP 2–5, and other unidenti-
fied D genes and their length varied from 7 to 11 aa (Fig. 6
c). In contrast, the incipient GCs in MZ mice on day 8
were dominated by the non-V186.2 analogue genes; only
20% of GC B cells used the V186.2 segments, half of which
were rearranged to DFL16.1/2 genes (Fig. 6 a). Unlike the
early AFC repertoire, AFC recovered from MZ mice on
day 14 expressed the canonical V186.2/DFL16.1/2 rear-
rangements (Fig. 6 a) with uniform CDR3 length (11–12
aa) (not depicted). Moreover, the repertoire of these late
AFC was similar to that of the GC, and clones with identi-
cal CDR3 were found in both cell populations.
As expected, most of the V186.2 sequences recovered
from early AFC foci in MZ mice were unmutated (27);
only one focus contained somatically mutated AFC with
an average of 1.2 mutations/VH (Table III). It is unlikely
that the mutated AFC originated from the rare, nascent
GCs in MZ mice because the focus was microdissected
from a splenic region devoid of PNA  follicles, and the
VD gene repertoire of early AFC in these mice was very
different from GC/late AFC repertoire. Thus, consistent
with previous studies (21), the presence of mutations in
early MZ AFCs suggests that some MZ B cells are immu-
nologically experienced.
In FO mice, microdissection of the rare, early AFC for
repertoire analysis was not technically feasible as they were
not organized in foci (Fig. 2 f). However,  50% of GC B
cells on day 8 used the V186.2 segment, and this propor-
tion increased further on day 14, which is typical of the
repertoire of NP-reactive GCs in intact BL/6 mice (20).
Approximately half of the V186.2 segments in FO GCs
were rearranged to DFL16.1/2 (Fig. 6 b). Day 14 AFCs in
these mice expressed a similar repertoire as the GC B cells
and often shared CDR3 of uniform length (11–12 aa).
Somatic Hypermutation in GC and Late AFC. Studies
have shown that immunocompromised mice (28, 30) or
mice immunized with the bacterial epitope phosphoryl-
choline (28, 29) may develop GCs that appear to be mor-
phologically normal but are deficient in somatic mutation
Figure 5. Kinetics of IgM (a) and IgG (b) serum Ab
responses after single injection of 40  g of NP-CGG/
alum in mice reconstituted with purified MZ B cells
(MZ, filled symbols), FO B cells (FO, open symbols),
and whole splenic B cells (  and  ) plus TH cells.
Each symbol represents one animal. Two independent
experiments are shown using circles (  and  ), triangles
(  and  ) and different crosses (  and  ). The points
below the horizontal line represent negative sera (titer
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and/or affinity maturation. Therefore, it was important to
assess whether the GCs in both MZ and FO mice sup-
ported somatic hypermutation in the V186.2  B cells.
Other VH clonotypes, which were identified by hybridiza-
tion with a crossreactive DNA probe (see Materials and
Methods) were not sequenced. As shown in Table III,
 60–70% of V186.2 sequences from day 8 GCs were mu-
tated, with an average of 1.7 mutations/VH in FO mice and
1.9 mutations/VH in MZ mice. These numbers increased
to 2.5 mutations/VH and 2.8 mutations/VH, respectively,
by day 14, which is consistent with the mutation frequen-
cies observed in the V186.2  GC B cells in NP-immu-
nized intact C57BL/6 mice (20). There were high ratios of
replacement to silent (R/S) mutations in CDR1 and 2, in-
dicative of positive selection in both FO (R/S   8) and
MZ (R/S   11) GCs (Table III, day 14).
On day 14, the majority of AFCs in both FO and MZ
mice was somatically mutated (Table III) with high R/S
ratios in CDRs and the canonical NP-specific mutation in
VH position 33 that replaces Trp(W) with Leu (L) (27),
which are unmistakable signs of their origin from GC. In-
deed, clonally related AFC and GC cells that shared so-
matic mutations were occasionally recovered from adjacent
sites. In the case shown in Fig. 7, sequences from two foci,
AFC-5 and AFC-20, shared four mutations with the adja-
cent GC-5, and shared five additional mutations with each
other. The sequences from AFC-5 also contained seven
unique mutations. Because of limited sampling, we cannot
determine whether all AFC mutations occurred in the GC
or whether the process of somatic hypermutation was per-
petuated in the AFC focus.
Antibody Affinity and L Chain Repertoire. We next asked
whether the distinctive repertoire of the early AFC response
in MZ mice is reflected in the serum Ab quality. Unexpect-
edly, the NP-specific IgG in MZ mice had higher affinity on
days 8 and 14, as indicated by the relative binding to NIP4-
BSA/NIP18-BSA (Fig. 8 c). IgG from FO mice did not bind
to NIP4-BSA on day 8 and only matured a little by day 14.
Figure 6. Summary of V/D gene recovery from
NP-reactive AFC and GC in mice reconstituted with
MZ B cells plus TH (a) or FO B cells plus TH (b) at day
8 and day 14 after immunization with NP-CGG/alum.
Between 400 and 600 clones from 10–15 independent
PCR products were screened for VH gene expression.
The data are expressed as the percentage of cloned cells
expressing V186.2/DFL16.1/2 rearrangements (blue),
V186.2 rearranged to other D segments (red), and ana-
logue VH segments of the V186.2/V3 gene family
(yellow). (c) Nucleotide sequences of V186.2/D rear-
rangements recovered from AFC foci on day 8 after the
immunization in mice reconstituted with MZ B cells.Song and Cerny 1931
Table III. Somatic Mutations in VH186.2 Genes in FO- and MZ-derived AFC Foci and GC
Cells sampled
Days after
immunization
Recipients
(mice/group)a
Number of
sites sampledb
VH186.2 sequences
Mutations/VH
(average)
W33L 
mutationc
R|Sd
Total Mutated (%) CDR1   2F W
AFC foci 8 FO (2 mice) ND
MZ (2 mice) 1 12 0 0 0
2e 10 0 0 0
1e 8 60 1.2 0
14 FO (2 mice) 3 20 85 1.5 12 10.0 1.7
MZ (3 mice) 4 18 95 1.6 7 8.0 1.7
GC 8 FO (2 mice) 4 25 62 1.7 0
MZ (2 mice) 2 14 75 1.9 0
14 FO (2 mice) 7 32 90 2.5 8 8.0 1.4
MZ (3 mice) 4 13 100 2.8 0 11.0 2.1
aNumber of scid mice reconstituted with either FO B cells or MZ B cells plus TH cells and sacrificed on the indicated day after immunization with
NP-CGG.
bAt least one focus ( 20–50 AFC) and one GC was microdissected from each spleen.
cNumber of sequences with tryptophan → leucine replacement in VH position 33.
dReplacement/silent mutation ratio.
eThese foci were dissected from the same spleen.
Figure 7. V186.2/DFL16.2 nucleotide se-
quences recovered from adjacent GC #5 and AFC
foci #5 and #20 in mice reconstituted with FO B
cells on day 14 after the immunization. Colored
bases indicate common point mutations that were
found in sequences from all three sites (green) and
those found in GC #5 and AFC #5 (blue), GG #5
and AFC #20 (purple), and AFC #5 and AFC #20
(orange).Immune Responses of Marginal Zone B Cells to a T-dependent Antigen 1932
The Abs from both groups reached nearly equivalent bind-
ing to NIP4/NIP18 after 1 mo. The anti-NP antibody in
MZ and FO mice also differed in the L chain isotype. Al-
though Abs with lambda chain were prevalent in both
groups (Fig. 8 a), the MZ mice had  2 log higher titers of
kappa  anti-NP Ab than the FO mice (Fig. 8 b); the two
groups reached similar levels of kappa  Ab after 2 mo. An
increased proportion of kappa  Ab is typical of the late pri-
mary or secondary response to NP (31). Together, the non-
canonical CDR3 repertoire of AFC, the higher affinity of
early Ab, and the higher proportion of kappa  Ab suggest
that the rapidly responding NP-specific MZ B cells had been
immunologically preselected for their role in early responses.
Anamnestic IgM and IgG Responses. Lastly, we exam-
ined whether the mice reconstituted with either MZ or
FO B cells and primed with NP-CGG/alum developed
immunological memory. Both groups maintained high ti-
ters of anti-NP IgG even at 3 mo after the immunization,
which could have masked the de novo response to Ag
boost. Therefore, the splenocytes from the NP-CGG–
primed MZ and FO mice were adoptively transferred into
C57BL/6/scid recipients, and the recipients were chal-
lenged with 10  g of NP-CGG in PBS. An administration
of low dose of soluble NP-CGG induces a rapid, anamnes-
tic Ab response in mice that were primed with Ag in alum
adjuvants, but it does not elicit an appreciable Ab response
in naive mice. Note that the scid recipients of splenocytes
from unprimed donors indeed failed to mount any IgM
(Fig. 8 d) or IgG (Fig. 8 e) Ab response to the boost with
10  g of soluble NP-CGG. In contrast, the recipients of
Ag-primed lymphocytes from either MZ or FO donors re-
sponded to the challenge by a brisk anamnestic IgG re-
sponse that was comparable in kinetics and magnitude (Fig.
8 e). Surprisingly, the recipients of primed MZ cells (but
not FO) also mounted a rapid IgM response (Fig. 8 d),
which was not seen with naive cells (not depicted), indicat-
ing that the proclivity of MZ B cell for IgM production is
maintained even in the long-term memory cell population.
Discussion
We have delineated the functional differences and simi-
larities between MZ and FO B cells in response to a TD
antigen in vivo. We demonstrate, for the first time, that
Figure 8. Light chain usage (a and b), antibody affinity (c), and anamnestic response (d and e) in mice reconstituted with MZ and FO B cells. Total
anti-NP serum antibody with lambda (a) and kappa (b) light chains in mice reconstituted with MZ cells ( ) or FO cells ( ) (mean titer in three to seven
mice per interval   SD). Relative affinities of anti-NP serum IgG1 Ab in mice reconstituted with MZ B cells   TH ( ) or FO B cells   TH ( ) were
determined at various intervals after the immunization with NP-CGG (see Materials and Methods). Zero values show the IgG1 with no binding to NP4-
BSA (c). Secondary anti-NP IgM (d) and IgG (e) serum Ab titers in scid mice reconstituted with spleen cells from various donors: antigen-primed MZ
mice (  and  ), antigen-primed FO mice (  and  ), or normal, naive BL/6 mice ( ). Each symbol indicates one recipient. The recipients were either
challenged with 10  g of soluble NP-CGG ( ,  , and  ) or not (  and  ).Song and Cerny 1933
hapten-reactive MZ B cells are functionally and clonally
heterogeneous and that they are capable of forming GCs.
Although the bulk of the early primary response by MZ
and FO is skewed to the AFC and GC formation, respec-
tively, evidence is provided that the functions of these two
cell subsets, in fact, overlap.
MZ B cells have been identified previously as a primary
source of early AFC response to TI Ags (8). The potential
role of these cells in response to TD hapten–protein conju-
gates was explored by Liu et al. (19) using immunohisto-
logical techniques. In their view, the Ag challenge induced
a rapid movement of hapten-specific B cells into the MZ
where they differentiated into hapten-binding cells, which
were regarded as likely candidates for transport of immune
complexes back to the follicles. However, the hapten-
binding MZ B cells appeared to have no relationship to the
plasmacytes that arose concurrently in the splenic red pulp.
We now provide direct evidence that MZ B cells are the
major source of the early primary AFC plasmacytes in re-
sponse to a TD Ag.
The repertoire of the rapid MZ AFC response to NP
had several unexpected features. The usage of VH186.2
gene was higher than that typically observed in the primary
GC (20, 26; Fig. 6 a), however, this VH segment was rarely
joined to the DFL16.1/2 gene, contrary to the canonical
V186.2/DFL16.1 rearrangements that are found later in the
NP-driven response (21–23; Fig. 6, a and b). Interestingly,
the use of noncanonical D segments was shown to be a
characteristic of secondary anti-NP repertoire based on
analysis of hybridomas (21). Here we show that in addition
to the unique VD repertoire, the early MZ-derived AFC
contained occasional point mutations in the VH gene and
produced circulating IgG Ab that had higher antibody af-
finity for NP than the primary IgG Ab produced by FO B
cells. These results suggest that the first wave of AFC arises
from a subset of NP-reactive B cells that have been selected
into MZ pool by stimulation with an NP-crossreactive
epitope, either a self-ligand (3) or an environmental Ag.
We hypothesize that this “natural priming” fortuitously
stimulates an expansion of cell clones that react with NP
more avidly than the naive NP-specific B cells. The theory
that the BCR of these cells use kappa light chains instead of
lambda may be conjectured from the observation of higher
levels of kappa  anti-NP Ab in the MZ mice (Fig. 8 b).
Figure 9. Working model of splenic B cell responses to a TD antigen. Antigen-reactive (“naturally primed”) MZ B cells produce the large foci of early
AFCs (1) similar to the model of TI response in reference 5. Clonotypically distinct MZ B cells become activated (2) and either enter GC (4) or differentiate
into late AFC (3); the majority of late AFCs derive from GC (5). MZ-derived memory cells (6) produce anamnestic IgM and IgG Ab upon restimulation.
FO B cells are the main source of GC (2a and 4a), producing late AFCs either directly (3a) or from GC (5a) and generating IgG-producing memory B
cells (6a). Early AFC may be formed either by an FO B cell subset or by the GC-committed population (1a).Immune Responses of Marginal Zone B Cells to a T-dependent Antigen 1934
The adoptive cell transfer system revealed the potential
of purified MZ B cells to generate conventional GC upon
stimulation with TD Ag in the presence of Ag-primed TH
cells. Up to 20% of B cells in the recipient spleen expressed
the GL-7 marker of GC, which is within the upper ranges
of GC reaction reported in other studies (27, 32). Using B
cell subsets expressing different Ly5 alleles, we showed that
the majority of GCs in MZ-reconstituted mice came from
the MZ cells rather than from contaminating immature
cells and that MZ B cells were able to generate the GL-7 
GC cells even in the presence of excess FO B cells. In chi-
meras that received Ly5.2  MZ and Ly5.1  FO cells, indi-
vidual PNA  splenic GC were entirely either Ly5.1 posi-
tive or negative. We have not observed a mosaic staining
pattern with a mixture of PNA Ly5.1  and PNA Ly5.1 
cells within a GC (Fig. 4), suggesting that individual cen-
ters were founded either by MZ or FO B cell precursors,
consistent with the theory of a pauciclonal origin of GC
(20). Thus, our data clearly demonstrate that MZ B cells
are functionally heterogeneous, containing distinct precur-
sors for the rapid AFC formation and for GC formation
(Fig. 9). When BCR on MZ cells binds Ag, they move
rapidly to the splenic T cell zones (4, 33). We conjecture
that some of these cells receive helper signals for migration
to follicles and GC formation (Fig. 9).
It was surprising that MZ B cells, despite their rapid
switch from IgM to IgG, continued to produce high levels
of IgM Ab during a 3-mo period after the immunization
and that they could also produce a robust rapid IgM anam-
nestic response. This implies that a significant proportion of
Ag-stimulated MZ B cells does not undergo class-switch
recombination (CSR) and that the cells remain at the VDJ/ 
configuration even during their differentiation into mem-
ory B cells in GC. An induction of a robust IgM memory
by priming with TD antigens has been observed previously
(34, 35); our results now identify MZ B cells as the source
of this IgM memory. It may be that MZ B cells respond
less well to TD signals (cytokines or cognate stimuli) that
are presumably required for the accessibility of DNA for
CSR downstream of C  (36). An alternative mechanism
for the long-term IgM-producing B cells is suggested from
the recent demonstration by Dudley et al. (37) that in-
creased activity of AID, an enzyme required for CSR, may
lead to deletion of the 5  internal switch   sequence in
some IgM-producing B cells, thus preventing any further
isotype switch. We hypothesize that this mechanism occurs
in the “naturally activated” MZ B cells but not in the FO B
cells.
The working model in Fig. 9 proposes that the FO cells
are committed mainly to GC formation and the late pri-
mary AFC. It is not clear whether the first anti-NP serum
Ab in FO cell–reconstituted mice originated from the rap-
idly expanding GC or from an independent, small popula-
tion of AFC precursors (Fig. 9, 1a). Still, the model of TD
response in Fig. 9 emphasizes distinction between the earli-
est wave of AFC from MZ B cells and the later AFC that
were produced by both MZ and FO cells, which had a VH
gene repertoire similar to that of respective GC. Clonally
related cells with shared point mutations were readily re-
covered from AFC foci and GC on day 14, indicating that
the AFCs originated from those B cells within GCs that
up-regulate Blimp-1 and differentiate into plasmacytes (38)
(Fig. 9, 5 and 5a). However, a proportion of the late AFCs
was unmutated; yet, some of them may also share CDR3
with GC B cells (39). This suggests that daughters of single,
antigen-driven MZ and FO B cells may either form GCs
and/or become plasmacytes (Fig. 9, 3, 3a, 4, and 4a).
Our results support the notion that the response of MZ
B cells to a single epitope, NP, can be heterogeneous both
functionally and clonotypically. Further studies are needed
to test the hypothesis that MZ B cells include distinct
clones, either which produce the rapid AFC response or
those with different genealogy and genetic program that
form the GC.
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